International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
Condition(s):Kidney CancerLast Updated:May 6, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Kidney CancerLast Updated:May 6, 2022Recruiting
Condition(s):Renal CancerLast Updated:August 31, 2022Active, not recruiting
Condition(s):Renal Tumor Histology; Kidney Cancer; Renal Cell Carcinoma; Familial Renal Cancer; HLRCC; VHL Syndrome; BAP1 Tumor Predisposition Syndrome; FLCN Gene Mutation; ALK Gene Mutation; FH Gene Mutation; Birt-Hogg-Dube Syndrome; MET Gene Mutation; Cutaneous Leiomyoma; Cutaneous Leiomyomata With Uterine LeiomyomataLast Updated:August 31, 2023Recruiting
Condition(s):Renal TumorLast Updated:September 5, 2021Completed
Condition(s):Kidney CancerLast Updated:December 16, 2021Completed
Condition(s):Kidney NeoplasmsLast Updated:June 4, 2015Terminated
Condition(s):Renal TumorLast Updated:March 18, 2022Unknown status
Condition(s):Kidney CancerLast Updated:January 30, 2024Recruiting
Condition(s):Advanced Kidney CancerLast Updated:October 19, 2020Withdrawn
Condition(s):Renal TumorLast Updated:October 22, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.